{ Phase I-IIb }
DCR Phase I facility built for efficient, successful studies
The 42-bed DaVita Clinical Research (DCR) Phase I clinic is located within the Hennepin County Medical Center in Minneapolis, Minnesota. This partnership with one of the upper Midwest’s most advanced Level III trauma medical centers, along with on-site hemodialysis and peritoneal dialysis facilitates 24-hour medical monitoring when conducting CKD studies.
The facility is efficiently designed with computerized EKG, three private client monitor rooms, three exam rooms, large treatment rooms, and an outpatient blood draw area. The sample processing laboratory features two refrigerated centrifuges.
The internal pharmacy is United States Pharmacopeia (USP) 797 compliant, meeting federal standards for pharmacy compounding with an ante room and clean room with compounding hood. It is also Minnesota Board of Pharmacy High Risk certified. This allows for the compound of all powders, liquids, solids, and gels that are non-sterile or sterile for a final product.
The internal pharmacy holds a state license, DEA license, and radiolabel license. DCR is equipped with secured access, video surveillance, and a repetitive monitoring system (Ping) for study drug and sample storage to ensure temperature control and chain of custody for accurate and timely data capture and review.
DCR is a Western Institutional Review Board (WIRB) preferred clinical research Phase I site. WIRB meets weekly and approval of studies occurs in less than 12 days from submission.
